Transforming medicine with exosome-enabled precision therapies
Evox Therapeutics is redefining treatment possibilities by combining the natural power of exosomes with advanced genome editing technologies.
Backed by leading investors and partners, Evox is advancing an innovative pipeline targeting high-impact conditions like ALS and SCA2, while also unlocking broader opportunities across genetic diseases. We are dedicated to transforming patient outcomes through cutting-edge science and unparalleled therapeutic innovation.
ExoEdit™
Evox has developed an unparalleled proprietary technology platform, ExoEdit™, to enable it to modify exosomes, to load drugs into exosomes, and to target the delivery of these exosomes to organs of interest. Evox has successfully demonstrated this capability by delivering drug-loaded exosomes into target organs including the central nervous system and other intractable tissues. Exosome-based drugs have the potential to address some of the limitations of protein, antibody, and nucleic acid-based therapies by enabling delivery to cells and tissues that are currently out of reach using other drug delivery technologies. Evox is leading the development within this emerging space and the company is poised to break new ground in the treatment of severe rare genetic disorders using its innovative exosome therapeutics.
At Evox, values are at the heart of how we operate, how we behave, and how we will drive the growth of our exciting company.
We developed the values internally with all our employees, ones which we could all identify and work with. The personal and professional development of our employees is important to us, and we strive to provide formal and informal feedback throughout the year.
This is the way we work at Evox.
Our Values
Teamwork
We collaborate to innovate
Respect
We encourage diversity
Accountability
We
strive for excellence
Discovery
We are passionate and creative